A new drug for Alzheimer’s is struggling to justify its price
Jay reinstein remembers where he was when he heard that the Food and Drug Administration (fda) had approved Aduhelm (aducanumab), a new Alzheimer’s drug. It was last June, and he was at Kohl’s, a department store, when he started getting news alerts on his phone. He asked a stranger outside the shop to take a picture of him jumping into the air, which he promptly posted on Facebook to share the news with family and friends. “It was an awesome feeling because it really felt li
New therapy may stop metastasis in triple-negative breast cancer
The oncoprotein MYC plays a role in promoting most human forms of cancer. Oncoproteins are produced by genes that promote cancer. Scientists have found that MYC encourages the proliferation of cancer cells and increases their survival. While MYC’s role in the development of tumors is clear, scientists are split on whether MYC promotes metastasis — the spread of tumors to other parts of a person’s body. Some scientists suggest MYC encourages this spread, while others indicate
What are Alzheimer's early symptoms?
As people get older, more and more studies are trying to detect the initial symptoms of Alzheimer’s disease, even ones that may appear 15 years before its onset to stop or delay it in the future. A multidisciplinary team of researchers from the Aramis project, in collaboration with the Paris Brain Institute, analyzed anonymous health records from approximately 80,000 patients. The scientists identified ten pathologies that were seen more frequently in patients who reported de
How often is breast cancer overdiagnosed? New research finds true cases far outweigh false alarms
Catching cancer early in a mammogram can be life-saving — smaller tumors are easier to remove surgically, and therapy often has a much greater effect. But paradoxically, breast cancer screening also sometimes picks up tumors that would have caused less harm if they’d remained hidden. ARTICLE
